Vigil Neuroscience 株価情報 (NASDAQ: VIGL)

最新ニュース Vigil Neuroscience (NASDAQ:VIGL) 株価情報

VIGIL NEUROSCIENCE INC

Vigil Neuroscience

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

Vigil Neuroscience Inc

News

General

ALCO

Alico And Tropicana Terminate Agreement Effective Immediately; All Obligations Under Agreement To Be Settled By July 15, 2025

President Trump is a bold leader and businessman who knows how to get the best deal for America, American workers and American manufacturing.
U. S. Steel will remain American, and we will grow bigger and stronger through a partnership with Nippon Steel that brings massive investment, new technologies and thousands of jobs over the next four years.
U. S. Steel greatly appreciates President Trump's leadership and personal attention to the futures of thousands of steelworkers and our iconic company.

United States Steel Corporation Issues Statement Following President Trump Decision

Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) has outperformed the market over the past 10 years by 4.14% on an annualized basis producing an average annual return of 14.69%. Currently, Hilton Worldwide Holdings has a market capitalization of $58.18 billion. 
Buying $1000 In HLT: If an investor had bought $1000 of HLT stock 10 years ago, it would be worth $3,934.08 today based on a price of $244.77 for HLT at the time of writing.
<h3>Hilton Worldwide Holdings's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748036713_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

TCRT

Alaunos Therapeutics Enters Equity Purchase Agreement With Mast Hill; Mast Hill To Purchase Up To $25M Of Common Stock

Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) has outperformed the market over the past 20 years by 4.37% on an annualized basis producing an average annual return of 12.58%. Currently, Molina Healthcare has a market capitalization of $16.87 billion. 
Buying $100 In MOH: If an investor had bought $100 of MOH stock 20 years ago, it would be worth $1,069.73 today based on a price of $311.27 for MOH at the time of writing.
<h3>Molina Healthcare's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748035829_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Molina Healthcare 20 Years Ago Would Be Worth Today

Offerings

DWTX

Dogwood Therapeutics Files For Mixed Shelf Of Up To $150M

PSQH

PSQ Holdings Files For Offering Of Up To $50M Of Class A Common Stock

WIIM

CETY

Clean Energy Technologies shares are trading higher after the company announced it signed a non-binding offer with an European solar and wind development company for approximately $85 million.

Clean Energy Technologies Signs Non-Binding Offer With  European Solar And Wind Development Company; The Total Deal Size Is Estimated To Be ~$85M

urban-gro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and other commercial sectors, today announced that the Company received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") on May 21, 2025, stating that because the Company had not yet filed its its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 (the "Form 10-Q") and its Annual Report on Form 10-K for the fiscal quarter ended December 31, 2024 (the "Form 10-K"), the Company continues to be out of compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
This notification has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market.

UGRO

Urban-gro Receives Nasdaq Notification Of Non-Compliance

Triller Group Inc. ("Triller", "Triller Group" or "the Company") today announced that on May 20, 2025, it received a delinquency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC ("Nasdaq") due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the "Filing"). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC").

ILLR

Triller Group Receives Nasdaq Notification Of Non-Compliance

UBS Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) has outperformed the market over the past 5 years by 10.9% on an annualized basis producing an average annual return of 25.03%. Currently, UBS Gr has a market capitalization of $100.96 billion. 
Buying $100 In UBS: If an investor had bought $100 of UBS stock 5 years ago, it would be worth $305.49 today based on a price of $31.69 for UBS at the time of writing.
<h3>UBS Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748034917_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

TPET

Trio Petroleum To Suspend Operations At Mccool Ranch; Terminates Efforts To Buy Interest In Mccool Ranch

LiveOne And Podcastone Enter Securities Purchase Agreement; Liveone Sells Debentures For $15.25M

<h3>Gainers</h3>
<ul>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) stock rose 8.7% to $1.63 during Friday's after-market session. The company's market cap stands at $12.8 million. As per the press release, FY earnings came out 3 days ago. </li>
<li>Fly-E Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) shares rose 4.98% to $0.5. The company's market cap stands at $12.2 million. </li>
<li>Beachbody Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODI#NYSE">BODI</a>) stock increased by 4.93% to $3.83. The company's market cap stands at $26.8 million. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) stock rose 4.83% to $2.17. The company's market cap stands at $2.5 million. </li>
<li>One Group Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) stock rose 4.28% to $3.89. The company's market cap stands at $120.2 million. </li>
<li>Raytech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) shares rose 4.24% to $2.3. The company's market cap stands at $40.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) shares decreased by 8.3% to $1.0 during Friday's after-market session. The company's market cap stands at $53.5 million. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) stock declined by 8.04% to $0.09. </li>
<li>Yatra Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTRA#NASDAQ">YTRA</a>) shares decreased by 6.03% to $0.77. The company's market cap stands at $46.1 million. </li>
<li>Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) shares declined by 6.0% to $0.81. The company's market cap stands at $150.2 million. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) shares fell 5.89% to $1.76. The market value of their outstanding shares is at $2.4 million. </li>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) shares fell 4.83% to $0.27. The company's market cap stands at $30.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

The Beachbody Company, Inc. Class A Common Stock

BODI

DXLG

FLYE

GDHG

GORV

LESL

LXEH

STKS

YTRA

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>SCWorx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) shares moved upwards by 71.9% to $0.7 during Friday's after-market session. The company's market cap stands at $1.6 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock moved upwards by 24.8% to $0.24. The company's market cap stands at $7.7 million. </li>
<li>Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) shares rose 7.75% to $1.25. The company's market cap stands at $18.2 million. </li>
<li>Tourmaline Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRML#NASDAQ">TRML</a>) stock increased by 6.59% to $16.33. The market value of their outstanding shares is at $419.4 million. </li>
<li>Prenetics Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRE#NASDAQ">PRE</a>) shares moved upwards by 6.45% to $10.98. The market value of their outstanding shares is at $134.0 million. </li>
<li>Revelation Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REVB#NASDAQ">REVB</a>) shares increased by 6.17% to $2.58. The market value of their outstanding shares is at $2.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Prothena Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) shares decreased by 23.6% to $5.03 during Friday's after-market session. The market value of their outstanding shares is at $270.7 million. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) shares decreased by 10.38% to $0.21. The company's market cap stands at $2.3 million. </li>
<li>Meihua Intl Medical Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHUA#NASDAQ">MHUA</a>) shares declined by 7.86% to $0.36. The market value of their outstanding shares is at $9.1 million. </li>
<li>SINTX Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares decreased by 6.82% to $2.6. The market value of their outstanding shares is at $6.5 million. </li>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) stock decreased by 5.53% to $1.71. The market value of their outstanding shares is at $2.5 million. </li>
<li>Royalty Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>) shares fell 5.03% to $30.82. The company's market cap stands at $12.9 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BJDX

IMNN

KLTO

MHUA

PRTA

REVB

RPRX

SINT

TRML

VTAK

WORX

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Turbo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TURB#NASDAQ">TURB</a>) stock moved upwards by 6.5% to $2.46 during Friday's after-market session. The market value of their outstanding shares is at $27.1 million. </li>
<li>Agrify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGFY#NASDAQ">AGFY</a>) stock moved upwards by 6.16% to $25.49. The company's market cap stands at $49.7 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares increased by 5.88% to $0.61. The company's market cap stands at $3.6 million. </li>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares rose 5.57% to $0.38. The market value of their outstanding shares is at $4.8 million. </li>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock increased by 5.55% to $4.18. The market value of their outstanding shares is at $10.6 million. </li>
<li>Earlyworks Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) shares rose 4.65% to $2.02. The market value of their outstanding shares is at $6.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares decreased by 10.0% to $0.54 during Friday's after-market session. The market value of their outstanding shares is at $3.8 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares decreased by 8.63% to $0.18. The market value of their outstanding shares is at $26.4 million. </li>
<li>New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) shares decreased by 7.71% to $0.85. The company's market cap stands at $26.7 million. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) stock decreased by 5.01% to $0.85. The company's market cap stands at $17.3 million. </li>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) stock declined by 4.88% to $1.56. The market value of their outstanding shares is at $8.6 million. </li>
<li>Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) shares declined by 4.85% to $5.69. The company's market cap stands at $749.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AGFY

ATXG

ELWS

HOVR

JTAI

MNTS

SFHG

SGBX

TURB

VSTS

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>LeddarTech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDTC#NASDAQ">LDTC</a>) stock rose 6.4% to $0.35 during Friday's after-market session. The company's market cap stands at $13.0 million. </li>
<li>Saiheat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) stock rose 6.32% to $6.25. The market value of their outstanding shares is at $10.5 million. </li>
<li>Thumzup Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) shares rose 6.19% to $8.66. The market value of their outstanding shares is at $82.3 million. </li>
<li>Greenidge Generation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GREE#NASDAQ">GREE</a>) stock rose 5.66% to $1.68. The company's market cap stands at $19.2 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares moved upwards by 4.67% to $4.7. The company's market cap stands at $8.2 million. </li>
<li>Informatica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NYSE">INFA</a>) stock moved upwards by 4.65% to $23.6. The company's market cap stands at $7.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares decreased by 11.8% to $0.49 during Friday's after-market session. The company's market cap stands at $3.4 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares decreased by 8.25% to $3.95. The company's market cap stands at $2.4 million. </li>
<li>Syntec Optics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTX#NASDAQ">OPTX</a>) stock declined by 8.1% to $1.59. The market value of their outstanding shares is at $58.3 million. </li>
<li>PicoCELA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) stock decreased by 7.63% to $0.61. The market value of their outstanding shares is at $18.8 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) shares decreased by 6.64% to $0.37. The market value of their outstanding shares is at $9.5 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) shares fell 6.28% to $0.27. The company's market cap stands at $3.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AUUD

CLRO

GREE

INFA

LDTC

MOVE

OPTX

PCLA

SAIH

TAOP

TZUP

12 Information Technology Stocks Moving In Friday's After-Market Session

On May 22 iPower CFO Kevin Vassil Resigned Effective May 30, 2025; Chenlong Tan To Serve As Interim CFO Effective May 31, 2025

Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $157.8, with a high estimate of $167.00 and a low estimate of $147.00. This current average has decreased by 5.4% from the previous average price target of $166.80. 
<img src="https://www.benzinga.com/files/images/story/2025/1748034075_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Hamilton Lane among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$166.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Ken Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$167.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$157.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$147.00</td>
<td>$152.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$152.00</td>
<td>$169.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Hamilton Lane. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hamilton Lane compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Hamilton Lane's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Hamilton Lane's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HLNE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Hamilton Lane analyst ratings.</a>
<h2>Delving into Hamilton Lane's Background</h2>
Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.
<h3>A Deep Dive into Hamilton Lane's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Hamilton Lane's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 34.33% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Hamilton Lane's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 31.48% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 8.44%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.51%, the company showcases effective utilization of assets.
Debt Management: Hamilton Lane's debt-to-equity ratio is below the industry average. With a ratio of 0.57, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

HLNE

5 Analysts Assess Hamilton Lane: What You Need To Know

Press Releases

Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum

Earnings

Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference

Vigil Neuroscience Reports First Quarter 2025 Financial Results and Provides Recent Business Updates

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

VIGL Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Vigil Neuroscience, Inc. is Fair to Shareholders

Shareholder Alert: The Ademi Firm Investigates Whether Vigil Neuroscience Inc. Is Obtaining a Fair Price for Its Public Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, TXNM, SVT, PTIX on Behalf of Shareholders

Navitas (NASDAQ: NVTS) Surges on NVIDIA Deal – SNYR, VIGL, XAGE Lead $2 Stock Watch Now, More Inside

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL

Comments

Vigil Neuroscience

ニュース

最新ニュース Vigil Neuroscience (NASDAQ:VIGL) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル